综述

神经肽Y受体系统参与痛觉调制的研究进展

  • 赵舒煊 ,
  • 张东亮 ,
  • 沈伟 ,
  • 冯晓飞 ,
  • 刘正 ,
  • 袁文华 ,
  • 周海宇
展开
  • 1.兰州大学第二医院骨科,甘肃兰州市 730030;
    2.甘肃省骨关节疾病研究重点实验室,甘肃兰州市 730030
赵舒煊(1992-),男,汉族,甘肃敦煌市人,硕士研究生,主要研究方向:脊柱脊髓损伤的康复与治疗。

收稿日期: 2018-07-13

  修回日期: 2018-08-01

  网络出版日期: 2018-12-26

基金资助

甘肃省自然科学基金项目(No. 17JR5RA189)

Advance in Role of Neuropeptide Y Receptors System in Pain Modulation (review)

  • ZHAO Shu-xuan ,
  • ZHANG Dong-liang ,
  • SHEN Wei ,
  • FENG Xiao-fei ,
  • LIU Zheng ,
  • YUAN Wen-hua ,
  • ZHOU Hai-yu
Expand
  • 1. Department of Orthopedics, Second Hospital of Lanzhou University, Lanzhou, Gansu 730030, China;
    2. Key Laboratory of Bone and Joint Diseases of Gansu Province, Lanzhou, Gansu 730030, China

Received date: 2018-07-13

  Revised date: 2018-08-01

  Online published: 2018-12-26

Supported by

Supported by Natural Science Foundation of Gansu Province (No. 17JR5RA189)

摘要

神经肽Y受体系统是由神经肽Y (NPY)及其哺乳动物体内特异性受体组成的受体-配体系统,广泛参与哺乳动物内痛觉调制,以Y1受体(Y1R)和Y2受体(Y2R)两类亚型为代表。此类受体属G蛋白偶联受体,参与神经元膜信号转导,在中枢神经系统痛觉相关区域广泛分布,不同受体在颅内和脊髓水平分布具有特异性。NPY通过与Y1R和Y2R结合,维持痛觉传递过程的稳态。其中,脊髓水平结合Y1R可发挥镇痛效用,结合Y2R通常可发挥促痛作用。颅内调制功能则与特定区域核团功能有关。

本文引用格式

赵舒煊 , 张东亮 , 沈伟 , 冯晓飞 , 刘正 , 袁文华 , 周海宇 . 神经肽Y受体系统参与痛觉调制的研究进展[J]. 中国康复理论与实践, 2018 , 24(11) : 1284 -1287 . DOI: 10.3969/j.issn.1006-9771.2018.00.006

Abstract

The neuropeptide Y receptors system is a receptor-ligand system composed of neuropeptide Y and its receptors, which is represented by two subtypes, including Y1 receptor (Y1R) and Y2 receptor (Y2R). The system is widely involved in pain modulation in mammals. These receptors are G protein-coupled receptors, participating in neuronal membrane signaling. Neuropeptide Y receptors distribute in the pain-related regions of the central nervous system, play a variety of roles in maintains neuronal activity of pain transmission, relate to the specificity of distribution. At the spinal level, Y1R plays an analgesic role, whereas Y2R is usually related to pain-promoting. The system can also take part in cerebral pain modulation at different nuclei.

参考文献

[1] Dumont Y, Quirion R.NPY [M]// Kastin AJ. Handbook of Biologically Active Peptides. 2nd ed. Cambridge, Mass.: Academic Press, 2013: 883-888.
[2] Vähätalo LH, Ruohonen ST, Ailanen L, et al.Neuropeptide Y in noradrenergic neurons induces obesity in transgenic mouse models[J]. Neuropeptides, 2016, 55: 31-37.
[3] 董伟,宁炜,张翠珍, 等. 雌激素对去卵巢大鼠小脑皮质内脑源性神经营养因子及神经肽Y表达的影响[J]. 中国康复理论与实践, 2008, 14(11): 1033-1035.
[4] Schmeltzer SN, Herman JP, Sah R. Neuropeptide Y (NPY) and posttraumatic stress disorder (PTSD): a translational update[J]. Exp Neurol, 2016, 284: 196-210.
[5] Saraf R, Mahmood F, Amir R, et al.Neuropeptide Y is an angiogenic factor in cardiovascular regeneration[J]. Eur J Pharmacol, 2016, 776: 64-70.
[6] Pedragosa-Badia X, Stichel J, Beck-Sickinger AG.Neuropeptide Y receptors: how to get subtype selectivity[J]. Front Endocrinol (Lausanne), 2013, 4: 5.
[7] Sundström G, Xu B, Larsson TA, et al.Characterization of the neuropeptide Y system in the frog Silurana tropicalis (Pipidae): three peptides and six receptor subtypes[J]. Gen Comp Endocrinol, 2012, 177(3): 322-331.
[8] Michel MC, Beck-Sickinger A, Cox H, et al.XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors[J]. Pharmacol Rev, 1998, 50(1): 143-150.
[9] Yang Z, Han S, Keller M, et al.Structural basis of ligand binding modes at the neuropeptide Y Y 1 receptor[J]. Nature, 2018, 556(7702): 520-524.
[10] Wang Y, Wu Q, Hu M, et al. Ligand-and voltage-gated Ca2+ channels differentially regulate the mode of vesicular neuropeptide release in mammalian sensory neurons [J]. Sci Signal, 2017, 10(484): eaal1683.
[11] Brothers SP, Wahlestedt C.Therapeutic potential of neuropeptide Y (NPY) receptor ligands[J]. EMBO Mol Med, 2010, 2(11): 429-439.
[12] Lecat S, Belemnaba L, Galzi JL, et al.Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor[J]. Cell Signal, 2015, 27(7): 1297-1304.
[13] Arcourt A, Gorham L, Dhandapani R, et al.Touch receptor-derived sensory information alleviates acute pain signaling and fine-tunes nociceptive reflex coordination[J]. Neuron, 2017, 93(1): 179-193.
[14] Usoskin D, Furlan A, Islam S, et al.Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing[J]. Nat Neurosci, 2015, 18(1): 145-153.
[15] 付淼,任浩,罗芳. 脉冲射频对坐骨神经慢性压迫大鼠降钙素基因相关肽表达的远期影响[J]. 中国康复理论与实践, 2018, 24(5): 526-529.
[16] Brumovsky P, Hofstetter C, Olson L, et al.The neuropeptide tyrosine Y1R is expressed in interneurons and projection neurons in the dorsal horn and area X of the rat spinal cord[J]. Neuroscience, 2006, 138(4): 1361-1376.
[17] Dumont Y, Chabot JG, Quirion R.Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides[J]. Peptides, 2004, 25(3): 365-391.
[18] Veyrat-Durebex C, Quirion R, Ferland G, et al.Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain[J]. Neuropeptides, 2013, 47(3): 163-169.
[19] Peirs C, Williams SP, Zhao X, et al.Dorsal horn circuits for persistent mechanical pain[J]. Neuron, 2015, 87(4): 797-812.
[20] 王永刚,王栓科,时培晟,等. 神经肽Y在突出腰椎间盘组织中的表达及意义[J]. 中国疼痛医学杂志, 2012, 18(11): 663-666.
[21] Coronel MF, Villar MJ, Brumovsky PR, et al.Spinal neuropeptide expression and neuropathic behavior in the acute and chronic phases after spinal cord injury: Effects of progesterone administration[J]. Peptides, 2017, 88: 189-195.
[22] Naveilhan P, Hassani H, Lucas G, et al.Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor[J]. Nature, 2001, 409(6819): 513-517.
[23] Solway B, Bose SC, Corder G, et al.Tonic inhibition of chronic pain by neuropeptide Y[J]. Proc Natl Acad Sci U S A, 2011, 108(17): 7224-7229.
[24] Lemons LL, Wiley RG.Neuropeptide Y receptor-expressing dorsal horn neurons: role in nocifensive reflex and operant responses to aversive cold after CFA inflammation[J]. Neuroscience, 2012, 216: 158-166.
[25] Kostić S, Puljak L, Sapunar D.Attenuation of pain-related behaviour evoked by carrageenan injection through blockade of neuropeptide Y Y1 and Y2 receptors[J]. Eur J Pain. 2013, 17(4): 493-504.
[26] Malet M, Leiguarda C, Gastón G, et al.Spinal activation of the NPY Y1 receptor reduces mechanical and cold allodynia in rats with chronic constriction injury[J]. Peptides, 2017, 92: 38-45.
[27] Taylor BK, Fu W, Kuphal KE, et al.Inflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons[J]. Neuroscience, 2014, 256: 178-194.
[28] Taiwo OB, Taylor BK.Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors[J]. Pain, 2002, 96(3): 353-363.
[29] 时培晟,王栓科,王永刚,等. 神经肽Y2 受体在大鼠神经病理性痛中的作用[J]. 中华麻醉学杂志, 2013, 33(5): 565-568.
[30] Bourane S, Duan B, Koch SC, et al.Gate control of mechanical itch by a subpopulation of spinal cord interneurons[J]. Science, 2015, 350(6260): 550-554.
[31] Braz J, Solorzano C, Wang X, et al.Transmitting pain and itch messages: a contemporary view of the spinal cord circuits that generate gate control[J]. Neuron, 2014, 82(3): 522-536.
[32] Wang JZ, Lundeberg T, Yu LC.Anti-nociceptive effect of neuropeptide Y in periaqueductal grey in rats with inflammation[J]. Brain Res, 2001, 893(1): 264-267.
[33] Martins-Oliveira M, Akerman S, Tavares I, et al.Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine[J]. Pain, 2016, 157(8): 1666-1673.
[34] Alhadeff AL, Su Z, Hernandez E, et al.A neural circuit for the suppression of pain by a competing need state[J]. Cell, 2018, 173(1): 140-152.
[35] Cleary DR, Roeder Z, Elkhatib R, et al.Neuropeptide Y in the rostral ventromedial medulla reverses inflammatory and nerve injury hyperalgesia in rats via non-selective excitation of local neurons[J]. Neuroscience, 2014, 271: 149-159.
[36] Hartvigsen J, Hancock MJ, Kongsted A, et al.What low back pain is and why we need to pay attention[J]. Lancet, 2018, 391(10137): 2356-2367.
文章导航

/